Design and settings
A cross-sectional study investigating pain in patients with long-term dizziness was conducted by recruiting consecutive outpatients examined in a specialized Balance Clinic at an otolaryngology clinic at a University hospital. The patients were referred from primary or specialist care due to dizziness or balance problems.
Subjects
Patients aged 18–67, were eligible for inclusion if dizziness had lasted at least three months. Inclusion period was between August 2020 and January 2022 and a total of 164 patients were invited to participate in the study. Hospitalized patients and patients with neurological disorders (e.g. Multiple Sclerosis, Parkinson, stroke) or other serious comorbidities (e.g. amputations, alcoholism, ongoing chemotherapy) that potentially could affect physical functioning were excluded. Patients with vestibular schwannomas, divers investigated for neuro-otologic disorders, and patients from other health authority regions were also excluded. The patients had to have sufficient knowledge of Norwegian to fill in the questionnaires. Of the 164 eligible patients, four declined to participate, ten were later excluded, leaving 150 included patients (Fig. 1).
Data collection
Demographic variables
Age, gender, employment status, and duration of dizziness were registered.
Diagnoses
Diagnoses were set retrospectively by consensus among three experienced otorhinolaryngology specialists (F.G, S.H.G.N, J.E.B), according to the International Classification of Diseases (ICD-11). If the patient had several diagnoses, the one determined as the main diagnosis was included in the analysis. The diagnoses were further categorized into three categories corresponding to the ICD-11 coding system: Episodic vestibular syndrome (AB31 codes) including Benign Paroxysmal Positional Vertigo (BPPV), vestibular migraine, Ménière disease, and unspecified episodic syndromes; Chronic vestibular syndrome (AB32 codes) including Persistent Postural-Perceptual Dizziness (PPPD), vestibulopathy and specified or unspecified chronic syndromes, and other (MB23, MB44) including panic attack and abnormalities of gait and mobility (Table 1). The overall distribution of diagnoses is listed in Appendix 1.
Questionnaires
The Dizziness Handicap Inventory (DHI) (Tamber, Wilhelmsen, & Strand, 2009) quantifies the impact of dizziness on daily life. The 25-item questionnaire reflects physical, functional, and emotional aspects of dizziness. The response categories “yes” (4 points), “sometimes” (2 points), and “no” (0 points) present a total score from 0-100. Scores 0–29 represent a mild dizziness handicap, 30–60 moderate handicap, and > 60 severe handicap (Whitney, Wrisley, Brown, & Furman, 2004).
The Vertigo Symptom Scale – Short Form (VSS-SF) has satisfactory internal consistency and test-retest reliability and measures the frequency and severity of dizziness symptoms (Wilhelmsen, Strand, Nordahl, Eide, & Ljunggren, 2008). VSS-SF contains 15 items, 8 related to vertigo-balance and 7 related to autonomic-anxiety symptoms. Each item is scored on a 5-point scale (0–4), giving a total score of 60, where higher scores indicate higher severity. A total score of ≥ 12 points indicates severe dizziness (Yardley et al., 2004).
The Standardized Nordic Pain Questionnaire (SNQ) traces the localization of musculoskeletal pain or discomfort by the following question: “Do musculoskeletal troubles occur in a given population, and if so, in what part of the body are they localized?” (Kuorinka et al., 1987; Tschudi-Madsen et al., 2011). The respondent is asked to identify pain or discomfort in 10 different body sites: head, neck, shoulders, elbows, wrist/hands, upper back, lower back, hips, knees, and ankle/feet, during the last 7 days. A mannequin drawing illustrates the delimitation of the 10 different body sites. Localization and number of pain sites (NPS) are registered.
Pain intensity during the last seven days was reported by an 11-point (0–10) Numeric Rating Scale (NRS) where 0 equals “no pain at all” and 10 equals “worst imaginable pain”. NRS is reported to be valid and reliable (Ferreira-Valente, Pais-Ribeiro, & Jensen, 2011; Williamson & Hoggart, 2005). NRS ≤ 5 is considered mild pain-related interference 6 and 7: moderate interference, and ≥ 8, severe interference with functioning (Boonstra et al., 2016).
Dizziness Catastrophizing Scale (DCS) measures dizziness-related catastrophizing. It comprises 13 self-reported items, scored on a 5-point (0–4) Likert-type of scale where 0 equals “not at all” and 4 equals “all the time” (Pothier et al., 2018). The total score is 52 and higher scores indicate increased presence of catastrophizing. DCS has demonstrated good validity and reliability (Pothier et al., 2018). Validation of the Norwegian version is ongoing.
Statistical analysis
Descriptive statistics were used for demographic data, test scores, prevalence of pain, and pain pattern distribution; and are presented as mean, median, and frequency distribution as appropriate. Continuous variables were assessed and deemed normally distributed using visual inspections of histograms and qq-plots.
Linear regression analysis was used to estimate the association between pain (NPS and NRS) as dependent variables and dizziness (VSS-SF, DHI, DCS) as independent variables, and was examined in crude and adjusted models. Confounding variables (age and sex) were included in the adjusted regression models. The alpha level was set to 0.05. Of the 150 included participants, four had missing data, which was deemed insignificant to the results. The statistical software package Stata 17 was used for the data analysis.
Ethics
The study was approved by the Regional Ethical Committee (REK) (REK 2019/6849) and Norwegian Centre for Research Data (NSD), and committed to the criteria laid in the current (2013) Declaration of Helsinki (www.wma.net) and the personal data were administered following the standards of the General Data Protection Regulation (GDPR). To provide transparency, the study was registered in the Clinical Trials database (NCT04241822 27/01/2020) prior to the data collection. The authors declare no conflict of interest.